| Vol. 15.26 – 6 July, 2023 |
| |
|
|
| Scientists studied interactions between estrogen receptor-positive breast cancer cell lineages that were sensitive and resistant to ribociclib-induced cyclin-dependent kinase 4 and 6 inhibition. [Nature Communications] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers reported that tumor-secreted stanniocalcin 1 promoted the pulmonary metastasis of breast cancer by enhancing the invasiveness of tumor cells and promoting angiogenesis and lung fibroblast activation in the metastatic microenvironment. [Cell Death & Disease] |
|
|
|
| Investigators reported that Snail cooperated with GATA zinc finger protein p66β to transactivate genes in breast cancer cells. [Cell Death & Disease] |
|
|
|
| Scientists created a new model to better understand how the obese microenvironment alters nuclear receptor function in breast cancer. The obesity related cancer phenotype was PPARγ dependent. [Oncogene] |
|
|
|
| The authors investigated the function of SCRIB isoforms in breast cancer metastasis and their regulatory mechanisms. [Acta Pharmacologica Sinica] |
|
|
|
| To identify the genes pivotal for endocrine-resistance progression, researchers screened five datasets and found seven commonly dysregulated genes in endocrine-resistant breast cancer cells. [Communications Biology] |
|
|
|
| Investigators identified paired box protein 5 (PAX5) as the upstream regulator of miR-142-5p/3p through ALGGEN website and verified by series of assays in vitro and in vivo. [Molecular Medicine] |
|
|
|
| To evaluate the role of neuronatin (NNAT) on [Ca2+]i homeostasis, scientists used a combination of bioinformatics, gene expression and promoter activity assays, CRISPR gene manipulation, and more. [Molecular Medicine] |
|
|
|
| Researchers evaluated whether toosendanin could enhance the efficacy of paclitaxel, a common chemotherapeutic agent, against TNBC. [Advanced Biology] |
|
|
|
|
| The authors explore the current state of understanding of chromatin architecture in breast cancer subtypes and its potential role in defining their phenotypic characteristics. [Endocrinology] |
|
|
|
|
| The Biden administration has adopted a series of policies that attack critical steps needed to bring new treatments out of the lab and to the patients who need them. [STAT] |
|
|
|
|
| September 13 – 15, 2023 Seogwipo, South Korea |
|
|
|
|
|
| NCI Center for Cancer Research – Bethesda, Maryland, United States |
|
|
|
| Baylor College of Medicine – Houston, Texas, United States |
|
|
|
| UmeÃ¥ University – UmeÃ¥, Sweden |
|
|
|
| Institute of Cancer Research – London, England, United Kingdom |
|
|
|
| University of Vermont – Burlington, Vermont, United States |
|
|
|
|